Mobidiag Ltd:企業の製品パイプライン分析

◆英語タイトル:Mobidiag Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME16989PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company’s products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag’s Prove-it products include prove-it sepsis, prove-it bone and joint, and prove-it herpes for the detection and analysis of the microarrays. The company’s target therapy areas comprise in vitro diagnostics, gastrointestinal infections, and other infectious diseases. The company has operations in Finland, Sweden, the UK and France. Mobidiag is headquartered in Espoo, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Mobidiag Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Mobidiag Ltd Company Overview
Mobidiag Ltd Company Snapshot
Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
Mobidiag Ltd – Pipeline Analysis Overview
Mobidiag Ltd – Key Facts
Mobidiag Ltd – Major Products and Services
Mobidiag Ltd Pipeline Products by Development Stage
Mobidiag Ltd Pipeline Products Overview
Amplidiag RESP-4
Amplidiag RESP-4 Product Overview
GeneSpress
GeneSpress Product Overview
Novodiag Cartridge – Meningitis
Novodiag Cartridge – Meningitis Product Overview
Novodiag COVID-19 + InfA/B
Novodiag COVID-19 + InfA/B Product Overview
Novodiag RESP-4
Novodiag RESP-4 Product Overview
Novodiag System – Bloodstream Infections
Novodiag System – Bloodstream Infections Product Overview
Novodiag System – Central Nervous System Infections
Novodiag System – Central Nervous System Infections Product Overview
Novodiag System – Respiratory Infections
Novodiag System – Respiratory Infections Product Overview
Novodiag System – Sepsis
Novodiag System – Sepsis Product Overview
Novodiag System – Skin And Soft Tissue Infections
Novodiag System – Skin And Soft Tissue Infections Product Overview
Mobidiag Ltd – Key Competitors
Mobidiag Ltd – Key Employees
Mobidiag Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Mobidiag Ltd, Recent Developments
Feb 11, 2020: Mobidiag initiates development of molecular test for coronavirus
Feb 11, 2020: Mobidiag initiates development of molecular test for coronavirus
Jan 07, 2020: Mobidiag secures additional funding from Business Finland for rapid sepsis diagnostic test
Dec 11, 2019: Mobidiag Symposium on Innovative Molecular Diagnostics to be held for third year at RICAI annual meeting
Oct 29, 2019: Mobidiag signs new international agreements for distribution of its Amplidiag and Novodiag Diagnostic Solutions
Oct 10, 2019: Mobidiag’s Novodiag Stool Parasites test secures CE-IVD Mark
Jul 01, 2019: Mobidiag signs exclusive agreement with Pro Med Diagnostics for the distribution of Amplidiag and Novodiag Diagnostic Solutions in Africa
Jun 03, 2019: Mobidiag announces launch of Automobi Molecular Diagnostics
May 14, 2019: Investment Plan for Europe: Mobidiag secures EUR 25 Million from EIB
Mar 19, 2019: Mobidiag to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, the Netherlands
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
Mobidiag Ltd Pipeline Products by Equipment Type
Mobidiag Ltd Pipeline Products by Indication
Mobidiag Ltd, Key Facts
Mobidiag Ltd, Major Products and Services
Mobidiag Ltd Number of Pipeline Products by Development Stage
Mobidiag Ltd Pipeline Products Summary by Development Stage
Amplidiag RESP-4 - Product Status
Amplidiag RESP-4 - Product Description
GeneSpress - Product Status
GeneSpress - Product Description
Novodiag Cartridge - Meningitis - Product Status
Novodiag Cartridge - Meningitis - Product Description
Novodiag COVID-19 + InfA/B - Product Status
Novodiag COVID-19 + InfA/B - Product Description
Novodiag RESP-4 - Product Status
Novodiag RESP-4 - Product Description
Novodiag System - Bloodstream Infections - Product Status
Novodiag System - Bloodstream Infections - Product Description
Novodiag System - Central Nervous System Infections - Product Status
Novodiag System - Central Nervous System Infections - Product Description
Novodiag System - Respiratory Infections - Product Status
Novodiag System - Respiratory Infections - Product Description
Novodiag System - Sepsis - Product Status
Novodiag System - Sepsis - Product Description
Novodiag System - Skin And Soft Tissue Infections - Product Status
Novodiag System - Skin And Soft Tissue Infections - Product Description
Mobidiag Ltd, Key Employees
Mobidiag Ltd, Other Locations
Glossary

★海外企業調査レポート[Mobidiag Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Drake & Scull International (DSI):企業の財務・戦略的SWOT分析
    Drake & Scull International (DSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • The Walsh Group:企業の戦略・SWOT・財務分析
    The Walsh Group - Strategy, SWOT and Corporate Finance Report Summary The Walsh Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Western Energy Services Corp (WRG):企業の財務・戦略的SWOT分析
    Summary Western Energy Services Corp (Western) is an oilfield service company that offers contract drilling, well services and oilfield rental equipment services. The company offers services through Horizon Drilling, Eagle Well Servicing and Stoneham Drilling Corporation. It also provides rental ser …
  • Youlchon Chemical Co Ltd:企業の戦略・SWOT・財務情報
    Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Youlchon Chemical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ichor Medical Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ichor Medical Systems Inc (Ichor) is a medical equipment company that commercializes electroporation technology for the delivery of vaccines and DNA drugs. The company electroporation technology is used for the treatment and prevention of debilitating diseases. Its trigrid provides DNA drugs …
  • Woori Bank:企業のM&A・事業提携・投資動向
    Woori Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Woori Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • CANbridge Life Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Canbridge Life Sciences Ltd (Canbridge) is a biopharmaceutical company that offers development and commercialization of specialty healthcare products. The company’s pipeline products include CAN-008, an antibody-like CD95 receptor and Fc-fusion protein used to reduce cancer-cell migration in …
  • Maximus Inc.:企業の戦略・SWOT・財務情報
    Maximus Inc. - Strategy, SWOT and Corporate Finance Report Summary Maximus Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Invectys SA-製薬・医療分野:企業M&A・提携分析
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company’s product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal a …
  • Lotte Shopping Co., Ltd.:企業の戦略・SWOT・財務情報
    Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Haitong Securities Co., Ltd.:戦略・SWOT・企業財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NFP Corp.:企業のM&A・事業提携・投資動向
    NFP Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NFP Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Cold Spring Harbor Laboratory-製薬・医療分野:企業M&A・提携分析
    Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution’s research services include graduate research, research training, clinical research, quantitative biology research, postdoctoral research, disease …
  • Indian Oil Corporation Limited:企業の戦略・SWOT・財務分析
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Esterline Technologies Corporation:戦略・SWOT・企業財務分析
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Public Power Corporation SA (PPC):企業の財務・戦略的SWOT分析
    Public Power Corporation SA (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Umeme Limited (UMEME):企業の財務・戦略的SWOT分析
    Umeme Limited (UMEME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆